JPWO2021123996A5 - - Google Patents

Info

Publication number

JPWO2021123996A5

JPWO2021123996A5 JP2022537480A JP2022537480A JPWO2021123996A5 JP WO2021123996 A5 JPWO2021123996 A5 JP WO2021123996A5 JP 2022537480 A JP2022537480 A JP 2022537480A JP 2022537480 A JP2022537480 A JP 2022537480A JP WO2021123996 A5 JPWO2021123996 A5 JP WO2021123996A5

Authority

JP

Japan

Prior art keywords

antibody

pharmaceutical composition

cancer

tgf

weeks

Prior art date

2023-12-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 55
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 55
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 55
• 239000008194 pharmaceutical composition Substances 0.000 claims description 33
• 229950007213 spartalizumab Drugs 0.000 claims description 15
• 150000001413 amino acids Chemical group 0.000 claims description 14
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 13
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 13
• 206010028980 Neoplasm Diseases 0.000 claims description 10
• 201000011510 cancer Diseases 0.000 claims description 10
• 206010009944 Colon cancer Diseases 0.000 claims description 7
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 7
• 201000010099 disease Diseases 0.000 claims description 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
• 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 claims description 6
• 230000002062 proliferating effect Effects 0.000 claims description 6
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims description 5
• 239000012270 PD-1 inhibitor Substances 0.000 claims description 5
• 239000012668 PD-1-inhibitor Substances 0.000 claims description 5
• 229940121655 pd-1 inhibitor Drugs 0.000 claims description 5
• 206010006187 Breast cancer Diseases 0.000 claims description 4
• 208000026310 Breast neoplasm Diseases 0.000 claims description 4
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims description 4
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 4
• 206010039491 Sarcoma Diseases 0.000 claims description 4
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
• 201000002528 pancreatic cancer Diseases 0.000 claims description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
• 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 claims description 3
• 206010028537 myelofibrosis Diseases 0.000 claims description 3
• 208000022679 triple-negative breast carcinoma Diseases 0.000 claims description 3
• 206010061424 Anal cancer Diseases 0.000 claims description 2
• 208000007860 Anus Neoplasms Diseases 0.000 claims description 2
• 206010004593 Bile duct cancer Diseases 0.000 claims description 2
• 206010005003 Bladder cancer Diseases 0.000 claims description 2
• 206010005949 Bone cancer Diseases 0.000 claims description 2
• 208000018084 Bone neoplasm Diseases 0.000 claims description 2
• 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
• 206010061825 Duodenal neoplasm Diseases 0.000 claims description 2
• 206010014733 Endometrial cancer Diseases 0.000 claims description 2
• 206010014759 Endometrial neoplasm Diseases 0.000 claims description 2
• 206010062878 Gastrooesophageal cancer Diseases 0.000 claims description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 claims description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
• 206010025323 Lymphomas Diseases 0.000 claims description 2
• 206010027406 Mesothelioma Diseases 0.000 claims description 2
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims description 2
• 206010061306 Nasopharyngeal cancer Diseases 0.000 claims description 2
• 206010052399 Neuroendocrine tumour Diseases 0.000 claims description 2
• 206010033128 Ovarian cancer Diseases 0.000 claims description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
• 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
• 206010060862 Prostate cancer Diseases 0.000 claims description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
• 206010038389 Renal cancer Diseases 0.000 claims description 2
• 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
• 206010054184 Small intestine carcinoma Diseases 0.000 claims description 2
• 208000021712 Soft tissue sarcoma Diseases 0.000 claims description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
• 229930006000 Sucrose Natural products 0.000 claims description 2
• 208000024770 Thyroid neoplasm Diseases 0.000 claims description 2
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
• 201000011165 anus cancer Diseases 0.000 claims description 2
• 208000026900 bile duct neoplasm Diseases 0.000 claims description 2
• 201000010881 cervical cancer Diseases 0.000 claims description 2
• 208000006990 cholangiocarcinoma Diseases 0.000 claims description 2
• 201000000312 duodenum cancer Diseases 0.000 claims description 2
• 201000006974 gastroesophageal cancer Diseases 0.000 claims description 2
• 201000010536 head and neck cancer Diseases 0.000 claims description 2
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
• 201000010982 kidney cancer Diseases 0.000 claims description 2
• 208000032839 leukemia Diseases 0.000 claims description 2
• 201000007270 liver cancer Diseases 0.000 claims description 2
• 208000014018 liver neoplasm Diseases 0.000 claims description 2
• 201000005202 lung cancer Diseases 0.000 claims description 2
• 208000020816 lung neoplasm Diseases 0.000 claims description 2
• 201000000050 myeloid neoplasm Diseases 0.000 claims description 2
• 208000016065 neuroendocrine neoplasm Diseases 0.000 claims description 2
• 201000011519 neuroendocrine tumor Diseases 0.000 claims description 2
• 229960003301 nivolumab Drugs 0.000 claims description 2
• 229960002621 pembrolizumab Drugs 0.000 claims description 2
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
• 229950010773 pidilizumab Drugs 0.000 claims description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
• 229940068977 polysorbate 20 Drugs 0.000 claims description 2
• 201000000849 skin cancer Diseases 0.000 claims description 2
• 239000005720 sucrose Substances 0.000 claims description 2
• 239000004094 surface-active agent Substances 0.000 claims description 2
• 201000002510 thyroid cancer Diseases 0.000 claims description 2
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
• 238000000034 method Methods 0.000 description 56
• 239000003112 inhibitor Substances 0.000 description 8
• 238000011319 anticancer therapy Methods 0.000 description 3
• 229940124650 anti-cancer therapies Drugs 0.000 description 1
• 238000011301 standard therapy Methods 0.000 description 1